SIGNIFICANCE OF ALLOANTIBODY STUDIES IN WOMEN DURING PREGNANCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To analyze the frequency of alloantibodies and to show their clinical significance for Rh-positive pregnant women. Subjects and methods. The frequency of anti-erythrocyte alloantibodies was studied in 2415 pregnant women. The gel agglutination assay was used to determine antibodies to erythrocyte antigens. Results. Antibodies to erythrocyte antigens were detected in 75 women. The detection rate of alloimmunized women was 3.1%. Among the sensitized women, there was a preponderance of Rh-negative women (78.7%). The Rh-negative women were found to have alloantibodies to antigens only in the Rhesus system. The common cause of allosensitization was anti-D. The Rh-positive women were detected to have alloantibodies to both antigens in the Rhesus system (anti-E, anti-сE, anti-c, anti-C, and anti-Cw) and to those in other ones (KELL, Lewis, and Lutheran). One woman with complicated pregnancy subsequently developed a severe posttransfusion hemolytic complication caused by anti-c antibodies. Antibodies to a k antigen in the KELL system were identified in another woman in our study. In this clinical case, anti-k antibodies unidentified during pregnancy made it impossible to transfuse blood components. Conclusion. The example of clinical cases shows the importance of screening anti-erythrocyte alloantibodies in Rh-positive pregnant women, which should be included in normative documents and introduced into routine practice.

Full Text

Restricted Access

About the authors

N. V MINEEVA

Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia

Email: a_mineev@mail.ru
Saint Petersburg 191024, 2nd Sovetskay str. 16, Russia

I. A PASHKOVA

S.V. Ochapovsky Territorial Clinical Hospital One, Ministry of Health of Russia

Email: irpash@mail.ru
Krasnodar 350068, 1 Мауа str. 167, Russia

I. I KROBINETS

Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia

Email: irina_laborant@mail.ru
Saint Petersburg 191024, 2nd Sovetskay str. 16, Russia

References

  1. Минеева Н.В. Группы крови человека. Основы иммуногематологии. СПб.; 2004. 188с
  2. Vaughan J.I., Warwick R., Letsky E., Nicolini U., Rodeck C.H., Fisk N.M. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am. J. Obstet. Gynecol. 1994; 171(1): 247-52.
  3. Нагорнева С.В. Диагностика тяжелых форм гемолитической болезни плода: автореф. дисс.. канд. мед. наук. СПб.; 2010. 28с.
  4. Gooch A., Parker J., Wray J., Qureshi H. Guideline for blood grouping and antibody testing in pregnancy. Transfus. Med. 2007; 17(4): 252-62.
  5. Порядок проведения иммуногематологических исследований у беременных, рожениц, плодов и новорожденных. Методическое письмо Минздравсоцразвития РФ. М.; 2008. 22с.
  6. Schonewille H., Doxiadis I.I., Levering W.H., Roelen D.L., Claas F.H., Brand A. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion. 2014; 54(8): 1971-80.
  7. Giefman-Holtzman O., Wojtowycz M., Kosmas E., Arial R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet. Gynecol. 1997; 89(2): 272-5.
  8. Gottvall T., Filbey D. Alloimmunization in pregnancy during the years 19922005 in the central west region of Sweden. Acta Obstet. Gynecol. Scand. 2008; 87(8): 843-8.
  9. Пашкова И.А. Обеспечение качества гемотрансфузионной терапии в многопрофильном стационаре при оказании больным высокотехнологичной хирургической помощи: автореф. дисс.. д-ра мед. наук. СПб.; 2014. 47с.
  10. Минеева Н.В., Пашкова И.А. Специфичность аллоантител беременных женщин и особенности течения гемолитической болезни новорожденных. Гематология и трансфузиология. 2002; 47(6): 35-7
  11. Schonewille H., van de Watering L.M., Loomans D.S., Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006; 46(2): 250-6

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies